Results 131 to 140 of about 20,249 (182)
Some of the next articles are maybe not open access.

Cutaneous Leishmaniasis

Journal of Special Operations Medicine, 2021
Leishmaniasis is a parasitic infection that can involve the skin, mucosal membranes, and internal organs. Soldiers are at highrisk of leishmaniasis when conducting operations in endemic regions. Medical providers should have a low threshold to consider Leishmaniasis as the cause of persisting skin lesions.
Elena M, Crecelius, Mark W, Burnett
openaire   +2 more sources

Cutaneous leishmaniasis

Clinics in Dermatology, 2007
Cutaneous leishmaniasis is a widespread tropical infection caused by numerous different species of Leishmania protozoa that are transmitted by sandflies. Its clinical presentations are extremely diverse and dependent on a variety of parasite and host factors that are poorly understood.
Mark S, Bailey, Diana N J, Lockwood
openaire   +5 more sources

Cutaneous leishmaniasis

British Journal of Plastic Surgery, 2000
The incidence of leishmaniasis is increasing globally due to population and environmental changes. Ease of worldwide travel and immigrant populations means that the UK surgeon is more likely to encounter cutaneous lesions. Two cases are presented and treatment options discussed.
S S, Rayatt, A L, Moss
openaire   +2 more sources

Disseminated Cutaneous Leishmaniasis

International Journal of Dermatology, 1989
Observation chez un patient presentant une plaque ulceree d'apparition progressive depuis 9 mois. Le patient avait sejourne en Irak pendant 3 ans et etait revenu en Inde 3 mois avant le developpement de la lesion. L'examen revele plusieurs autres plaques et un rash erythemateux dans le dos et sur les membres inferieurs.
V K, Sharma   +4 more
openaire   +2 more sources

Miltefosine and cutaneous leishmaniasis

Current Opinion in Infectious Diseases, 2012
Miltefosine is a new oral treatment against leishmaniasis. The evidence about its use in New and Old World cutaneous leishmaniasis is presented and discussed.Miltefosine is being tested with small clinical trials mainly in endemic cutaneous leishmaniasis regions of South America and Iran.
Paulo R L, Machado, Gerson, Penna
openaire   +2 more sources

Cryosurgery in cutaneous leishmaniasis

British Journal of Dermatology, 1982
Thirty patients with cutaneous leishmaniasis were treated with cryotherapy using a CO2 cryomachine and all were cured without noticeable scarring within 4-5 weeks, with no relapse. Histopathological examination showed that cryotherapy eradicated all parasites in less than 1 hour. Leishmania tropica, L. ethiopica and L.
A, Bassiouny   +4 more
openaire   +2 more sources

Cutaneous Leishmaniasis

Journal of Special Operations Medicine, 2015
Cutaneous leishmaniasis is the most common form of leishmaniasis, which also appears in mucosal and visceral forms. It is a disease found worldwide, caused by an intracellular protozoan parasite of which there are more than 20 different species. The disease is transmitted by the bite of an infected, female, phlebotomine sand fly, causing skin lesions ...
openaire   +2 more sources

Recurrent cutaneous leishmaniasis

Journal of the American Academy of Dermatology, 1983
A patient is presented who has a 71-year history of recurrent cutaneous leishmaniasis, despite treatment with antimonials, antituberculous drugs, and surgery. Classification and treatment of cutaneous leishmaniasis are discussed.
R A, Strick, M, Borok, H C, Gasiorowski
openaire   +2 more sources

Cutaneous and Mucocutaneous Leishmaniasis

Infectious Disease Clinics of North America, 2012
Tegumentary leishmaniases are caused by approximately 15 species of protozoa of the genus Leishmania. They prevail in tropical and subtropical areas of the Old and New World but human mobility also makes them a medical problem in nonendemic areas. Clinical manifestations may comprise cutaneous and mucocutaneous forms that may be localized, disseminated,
Hiro, Goto   +1 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy